Transketolase inhibitors have been shown to reduce the rate of proliferation of pancreatic adenocarcinoma cells in culture [54] while, conversely, stimulating transketolase activity in cancer cells using thiamine promoted tumor growth in mice [55]. The gene discussed is TKT; the disease is pancreatic adenocarcinoma.